• 1
    Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853860.
  • 2
    Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin's lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 2003; 4: 110119.
  • 3
    Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies: an international perspective. Hematol Oncol Clin North Am 2003; 17: 673696.
  • 4
    Knowles DN, Dalla-Favera R. AIDS-associated malignant lymphoma, In: BroderS, MeriganTC, BolognesiD. eds. Textbook of AIDS Medicine. Baltimore, William & Wilkins 1994: 431463.
  • 5
    Sandler AS, Kaplan LD. Diagnosis and management of systemic non-Hodgkin's's lymphoma in HIV disease. Hematol Oncol Clin North Am 1996; 10: 11111123.
  • 6
    Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90: 28632892.
  • 7
    Stetler-Stevenson M, Braylan RC. Flow cytometric analysis of lymphomas and lymphoproliferative disorders. Semin Hematol 2001; 38: 111123.
  • 8
    Willman CL, Stewart CC. General principles of multiparameter flow cytometric analysis: applications of flow cytometry in the diagnostic pathology laboratory. Sem Diagn Pathol 1998; 6: 312.
  • 9
    Roma A, Garcia A, Avagnina A et al. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry. Diagn Cytopathol 2002; 27: 271275.
  • 10
    French CA, Dorfman DM, Shaheen G, Cibas ES. Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis. Diagn Cytopath 2000; 23: 369374.
  • 11
    Finn WG, Peterson LC, James C et al. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol 1998; 110: 341346.
  • 12
    Subirá D, Castañón S, Aceituno E et al. Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice. Am J Clin Pathol 2002; 117: 952958.
  • 13
    Subirá D, Castañón S, Román A et al. Flow cytometry and the study of central nervous disease in patients with acute leukemia. Br J Haematol 2001; 112: 381384.
  • 14
    Macedo A, Orfao A, González M et al. Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis; implications for minimal residual disease studies. Leukemia 1995; 9: 993998.
  • 15
    Chhieng DC, Elgert P, Cohen JM et al. Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens. Diagn Cytopathol 2002; 26: 209212.
  • 16
    Taiwo BO. AIDS-related primary CNS lymphoma: a brief review. AIDS Read 2000; 10: 486491.
  • 17
    Yoshida S, Morii K, Watanabe M et al. Characteristic features of malignant lymphoma with central nervous system involvement. Surg Neurol 2000; 53: 163167.
  • 18
    Langerak AW, Van Den Beemd R, Wolvers-Tettero IL et al. Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferations. Blood 2001; 98: 165173.
  • 19
    Lima M, Almeida J, Santos AH et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3+/TCR-alfabeta(+) large granular lymphocytes: utility into the pathogenesis of the disease. Am J Pathol 2001; 159: 18611868.
  • 20
    Loken MR, Shah VO, Dattilio KL et al. Flow cytometric analysis of human bone marrow II. Normal B lymphocyte development. Blood 1987; 70: 13161324.
  • 21
    Fukushima PI, Nguyen PK, O'Grady P et al. Flow cytometric analysis of kappa and lambda light chain expression. Cytometry 1996; 26: 243252.
  • 22
    Anthony IC, Crawford DH, Bell JE. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain 2003; 126: 10581067.
  • 23
    Svenningsson A, Andersen O, Edsbagge M et al. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 1995; 63: 3946.